Skin Ulcer clinical trials

The registry lists 61 studies for Skin Ulcer across more than 10 countries. 14 are recruiting or about to start. 21 of them are mainly about Skin Ulcer (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its 7 narrower conditions too, such as Diabetic Foot: 2,085 studies, 432 open.

Get an email when these change. Save the Skin Ulcer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 27
Recruiting: 10
Status unknown: 10
Terminated: 6
Not yet recruiting: 3
Active, not recruiting: 3

Phase

Phase 2: 15
Phase 1: 7
Phase 4: 5
Phase 3: 4

Where

United States: 21
Germany: 5
Italy: 4
Papua New Guinea: 4
France: 3
United Kingdom: 3

Who runs them

RHEACELL GmbH & Co. KG (5) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (3) · Samaritan Biologics (2) · Oregon Health and Science University (2) · Calvary Hospital, Bronx, NY (1) · Sequence LifeScience, Inc. (1) · Chinese PLA General Hospital (1) · VA Office of Research and Development (1)

What is being tested here

Drugs under test in Skin Ulcer studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Acetic Acid	1	1	1
Guselkumab	0	0	1
Linezolid	0	1	1
Baricitinib	0	0	1
Arginine butyrate	0	0	1
Nitric Oxide	0	0	1
Becaplermin	0	1	1
Morphine	0	0	1

Coming up

2phase 3 studies under way

6studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6, phase 3 first

Apr 2027Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III) · Phase 3 · RHEACELL GmbH & Co. KG
Nov 2026Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers · Tides Medical
Nov 2026Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs · C5 Biomedical
Mar 2027Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers. · Samaritan Biologics
Aug 2027Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Oregon Health and Science University
Oct 2027Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers · Samaritan Biologics

Who these studies take

Of the 10 Skin Ulcer studies recruiting now, 9 (90%) set no upper age limit and 1 (10%) stop at 75 or younger. 1 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 10
Age	Women	Men
10	1 (10%)	1 (10%)
18	9 (90%)	9 (90%)
30	10 (100%)	10 (100%)
40	10 (100%)	10 (100%)
50	10 (100%)	10 (100%)
65	10 (100%)	10 (100%)
75	9 (90%)	9 (90%)
85	9 (90%)	9 (90%)

Across all 61 studies, recruiting or not: 16% stop at 75 or younger and 13% at 65; 26% take children; 0% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 61. Browse all 61 → or search them.